NASDAQ
Innovent Biologics, Inc. (IVBXF) has a free cash flow growth of 4366.81% as of Friday, May 29, 2026. This represents a 9076.00% increase compared to its 12-month average of -48.65%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.